Status:

WITHDRAWN

Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors

Lead Sponsor:

State University of New York - Upstate Medical University

Conditions:

Lung Neoplasm

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to compare the features that the pathologist sees, when examining a lung tumor under the microscope, to the way that the tumor appears on the computed tomography (CT) scan...

Detailed Description

Newer cross-sectional imaging methods allow improved visualization of anatomic detail-for example, high-resolution CT has a spatial resolution of less than 1 mm in all 3 dimensions. These imaging meth...

Eligibility Criteria

Inclusion

  • Subjects who have a lung tumor that is likely to be malignant
  • Subjects who have been referred for percutaneous needle biopsy
  • The target lesion must be at least 10 mm in short-axis dimension.
  • Subjects must have intravenous access.
  • No history of significant allergy to intravenous contrast.
  • Subjects must have sufficient renal function to receive intravenous contrast for enhancement of the CT images.

Exclusion

  • Vulnerable populations will be excluded.
  • Subjects who lack the capacity to provide consent
  • Subjects who are pregnant

Key Trial Info

Start Date :

January 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2011

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00638625

Start Date

January 1 2010

End Date

February 1 2011

Last Update

May 14 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SUNY Upstate Medical University

Syracuse, New York, United States, 13210